Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference18 articles.
1. Campbell B, Campbell M. NICE medical technologies guidance: a novel and rigorous methodology to address a new health technology assessment challenge. Appl Health Econ Health Policy. 2012;10(5):295–7.
2. O’Connell S, Dale M, Morgan H, Carolan-Rees G. MT323 GammaCore for Cluster Headache (external assessment report). 2019. https://www.nice.org.uk/guidance/mtg46/documents/supporting-documentation. Accessed 12 Nov 2020.
3. National Institute for Health and Care Excellence. gammaCore for cluster headache [MTG46]. National Institute for Health and Care Excellence. 2019. https://www.nice.org.uk/guidance/mtg46. Accessed 12 Nov 2020.
4. Silberstein SD, et al. Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT1 study. Headache. 2016;56(8):1317–32.
5. Goadsby PJ, et al. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a randomized, double-blind, sham-controlled ACT2 study. Cephalalgia. 2018;38(5):959–69.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献